HER2 + BREAST CANCER

Clinical trials for HER2 + BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HER2 + BREAST CANCER trials appear

Sign up with your email to follow new studies for HER2 + BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 6 Not yet finished but already full! 2 Completed 1 Terminated 3

New drug combo shows promise in Hard-to-Treat breast cancer

Disease control Completed

This study tested a new drug called taselisib combined with standard anti-HER2 therapies in 68 people with advanced HER2+ breast cancer. The goal was to find the safest dose and see if the combination could shrink tumors or slow the disease. While not a cure, the approach aims to…

Matched conditions: HER2 + BREAST CANCER

Phase: PHASE1 • Sponsor: Otto Metzger, MD • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

HER2 + BREAST CANCER

Get alerted when new HER2 + BREAST CANCER trials appear

New drug combo shows promise in Hard-to-Treat breast cancer